Zydus Life has breached the critical Rs 910 level, a zone that previously attracted significant buying interest and fueled the rally to its all-time high. A closer analysis reveals the formation ...
Zydus Lifesciences Ltd said it has successfully concluded a United States Food and Drug Administration (USFDA) surveillance inspection at its API Unit 1 in Ankleshwar in Gujarat. Inspection ...
Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...
1don MSN
Zydus Lifesciences, the Ahmedabad-based pharma giant, has started the intraday trade on Wednesday, March 19, on a positive note. This spurt in the share prices in the early session is a result of ...
They continued to hold celebrations for the dedicated runners every five years ... A classical pianist, she had never run in her life. Two years later, DuBois ran the same path as Benoit ...
Zydus Life share price: Pharmaceutical company Zydus Lifesciences shares were in demand on Monday, March 17, 2025, as the scrip popped 1.90 per cent in early trade to hit an intraday high of Rs 899.40 ...
Brightly dressed boys and girls mounted on horses and carts, accompanied by their guardians, make their way to a Buddhist ...
Immortal Ink on Laclede's Landing held a flash sale for '314 Day', offering $31 tattoos with a $4 tip for the occasion on ...
Zydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 mg & 100 mg) for IBS-D treatment. The company secured 180 days of shared ...
The University of Surrey is a global community of ideas and people, dedicated to life-changing education and research. We are ambitious and have a bold vision of what we want to achieve - shaping ...
The University of Surrey is a global community of ideas and people, dedicated to life-changing education and research. Set within its Guildford-campus, its 3,000 staff provide exceptional teaching and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results